Fewer new lesions, side effects differentiate fingolimod from dimethyl fumarateApril 28, 2016Multiple Sclerosis
ORATORIO Subgroup Analysis Looks at Baseline Enhancement Activity’s Effect on OutcomeMarch 23, 2016Multiple Sclerosis
Stem cell therapy for MS: Steady progress but not ready for general useFebruary 28, 2016Multiple Sclerosis
Brain atrophy may be a clinically relevant measure in PPMS: Data from INFORMSFebruary 26, 2016Multiple Sclerosis
